Posted by Michael Wonder on 30 Apr 2018
Fight over PHARMAC's switch to generic anti-depressant brand continues
27 April 2018 - Depression sufferers wanting to remain on old anti-depressant brand can – but at a cost.
PHARMAC's switch to a generic anti-depressant brand is causing concern as more Kiwi depression sufferers warn the change may be doing more harm than good.
Following the death of her husband in 2008, Christchurch woman Marise Jose, 54, began taking venlafaxine medication Efexor XR to treat her depression, anxiety and panic attacks.
